YAP1 and neoplasm: Recently, CA3 (CIL56), YAP1/TEAD inhibition was shown to strongly inhibit esophageal adenocarcinoma cell growth and induce strong anti-tumor effects by suppressing tumor cell proliferation, and cancer stem cell phenotype in a xenograft model with no apparent toxicity [102].